Regeneron Pharmaceuticals, Inc. (REGN)
Nasdaq: REGN · Pharmaceutical Preparations · Tarrytown, NY · filing with the SEC since 1995
Grade7.3
◀ Past 7.9● Present 8.5▶ Future 5.0
Who runs Regeneron Pharmaceuticals, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Schleifer Leonard S
Bd. Co-Chair, President & CEO. First filing Mar 2006, latest Jan 5, 2026, 9 filings in all.
Officers reporting now
8
of 19 people with a filing in the last fifteen months
Directors reporting now
11
27 people on the record since 2006
Officerssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Pitofsky Jason | SVP Controller | Feb 2024 | Nov 6, 2026 | 20 · $5.7M |
| Murphy Andrew J | Co-Chief Scientific Officer | Dec 2019 | Nov 5, 2026 | 27 · $3.2M |
| Fenimore Christopher R. | EVP Finance CFO | Mar 2017 | Nov 4, 2026 | none |
| Larosa Joseph J | EVP General Counsel and Secret | Sep 2011 | Nov 4, 2026 | 2 · $4.3M |
| Mccourt Marion | EVP Commercial | Feb 2018 | Nov 3, 2026 | 3 · $3.0M |
| Schleifer Leonard S | Bd. Co-Chair, President & CEO | Mar 2006 | Jan 5, 2026 | none |
| Yancopoulos George | Bd. Co-Chair, President & CSO | Jan 2006 | Jan 5, 2026 | none |
| Van Plew Daniel P | EVP & General Mgr, Industrial | Sep 2007 | Dec 11, 2025 | none |
Directorssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Zoghbi Huda Y | director | Sep 2016 | Nov 5, 2026 | 14 · $9.1M |
| Poon Christine A | director | Nov 2010 | Nov 4, 2026 | 6 · $7.6M |
| Sing George L | director | Jan 2006 | Nov 4, 2026 | 9 · $20.4M |
| Brown Michael S | director | Jan 2006 | Nov 3, 2026 | 1 · $1.7M |
| Guarini Kathryn | director | Sep 2023 | Nov 3, 2026 | 3 · $1.0M |
| Ryan Arthur F | director | Jan 2006 | Jul 7, 2026 | 48 · $400,000 |
| Bassler Bonnie L | director | Sep 2016 | Jan 8, 2026 | 2 · $1.8M |
| Coles N Anthony | director | Jan 2017 | Jan 6, 2026 | none |
| Goldstein Joseph L | director | Jan 2006 | Jan 6, 2026 | none |
| Schenkein David P | director | Sep 2023 | Jan 6, 2026 | none |
| Thompson Craig B. | director | Oct 2022 | Jan 6, 2026 | none |
Earlier names on the record9, newest filing first
Stahl Neil · officer · last filing Dec 2024Landry Robert E · officer · last filing Feb 2024Vagelos P Roy · officer · last filing Apr 2023Tessier-Lavigne Marc · director · last filing Jan 2023Sanofi · 10% owner · last filing Jun 2020Baker Charles A · director · last filing Jan 2018Terifay Robert J · officer · last filing Dec 2017Aberman Michael S · officer · last filing Jun 2017Powchik Peter · officer · last filing Dec 2016
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.